In comparison to Nbs with a highly charged C-terminal amino acid tag (Myc-His-tagged), the administration of untagged 177Lu-labeled anti-HER-2 Nb (2Rs15d) co-infused with gelofusine resulted in a decrease in renal retention (95%) while retaining tumor-targeting capacity [50]. Here, ERBB2 is linked to neoplasm.